Year |
Citation |
Score |
2023 |
Xu J, Zhong A, Zhang S, Chen M, Zhang L, Hang X, Zheng J, Wu B, Deng X, Pan X, Wang Z, Qi L, Shi K, Li S, Wang Y, ... ... Chen C, et al. KMT2D Deficiency Promotes Myeloid Leukemias which Is Vulnerable to Ribosome Biogenesis Inhibition. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2206098. PMID 37142882 DOI: 10.1002/advs.202206098 |
0.303 |
|
2022 |
Na F, Pan X, Chen J, Chen X, Wang M, Chi P, You L, Zhang L, Zhong A, Zhao L, Dai S, Zhang M, Wang Y, Wang B, Zheng J, ... ... Chen C, et al. KMT2C deficiency promotes small cell lung cancer metastasis through DNMT3A-mediated epigenetic reprogramming. Nature Cancer. PMID 35449309 DOI: 10.1038/s43018-022-00361-6 |
0.405 |
|
2020 |
Chen M, Chen X, Li S, Pan X, Gong Y, Zheng J, Xu J, Zhao C, Zhang Q, Zhang S, Qi L, Wang Z, Shi K, Ding BS, Xue Z, ... ... Chen C, et al. An epigenetic mechanism underlying chromosome 17p deletion-driven tumorigenesis. Cancer Discovery. PMID 32978226 DOI: 10.1158/2159-8290.CD-20-0336 |
0.44 |
|
2018 |
Zheng P, Zhang Y, Ye P, Wu W, Chen C, Liu Y. Cd24 Defects Recapitulates Features of Aging Hematopoiesis Biology of Blood and Marrow Transplantation. 24: S477-S478. DOI: 10.1016/j.bbmt.2017.12.573 |
0.398 |
|
2017 |
Liu Y, Chen C, Xu Z, Niu T, Lowe S. The impact of ALOX cluster loss in chromosome 17p deletions on cancer Genes and Diseases. 4: 12-13. DOI: 10.1016/J.Gendis.2016.10.008 |
0.355 |
|
2016 |
Liu Y, Chen C, Xu Z, Scuoppo C, Rillahan CD, Gao J, Spitzer B, Bosbach B, Kastenhuber ER, Baslan T, Ackermann S, Cheng L, Wang Q, Niu T, Schultz N, et al. Deletions linked to TP53 loss drive cancer through p53-independent mechanisms. Nature. PMID 26982726 DOI: 10.1038/Nature17157 |
0.418 |
|
2015 |
Ye P, Liu Y, Chen C, Tang F, Wu Q, Wang X, Liu CG, Liu X, Liu R, Liu Y, Zheng P. An mTORC1-Mdm2-Drosha axis for miRNA biogenesis in response to glucose- and amino acid-deprivation. Molecular Cell. 57: 708-20. PMID 25639470 DOI: 10.1016/j.molcel.2014.12.034 |
0.581 |
|
2015 |
Ye P, Liu Y, Chen C, Tang F, Wu Q, Wang X, Liu CG, Liu X, Liu R, Liu Y, Zheng P. An mTORC1-Mdm2-Drosha axis for miRNA biogenesis in response to glucose- and amino acid-deprivation. Molecular Cell. 57: 708-20. PMID 25639470 DOI: 10.1016/j.molcel.2014.12.034 |
0.581 |
|
2015 |
Appelmann I, Rillahan CD, de Stanchina E, Carbonetti G, Chen C, Lowe SW, Sherr CJ. Janus kinase inhibition by ruxolitinib extends dasatinib- and dexamethasone-induced remissions in a mouse model of Ph+ ALL. Blood. 125: 1444-51. PMID 25499760 DOI: 10.1182/Blood-2014-09-601062 |
0.411 |
|
2015 |
Wong C, Chen C, Wu Q, Liu Y, Zheng P. A critical role for the regulated wnt-myc pathway in naive T cell survival. Journal of Immunology (Baltimore, Md. : 1950). 194: 158-67. PMID 25429066 DOI: 10.4049/jimmunol.1401238 |
0.629 |
|
2015 |
Wong C, Chen C, Wu Q, Liu Y, Zheng P. A critical role for the regulated wnt-myc pathway in naive T cell survival. Journal of Immunology (Baltimore, Md. : 1950). 194: 158-67. PMID 25429066 DOI: 10.4049/jimmunol.1401238 |
0.629 |
|
2014 |
Chen C, Liu Y, Rappaport AR, Kitzing T, Schultz N, Zhao Z, Shroff AS, Dickins RA, Vakoc CR, Bradner JE, Stock W, LeBeau MM, Shannon KM, Kogan S, Zuber J, et al. MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia Cancer Cell. 25: 652-665. PMID 24794707 DOI: 10.1016/J.Ccr.2014.03.016 |
0.385 |
|
2013 |
Lu C, Venneti S, Akalin A, Fang F, Ward PS, Dematteo RG, Intlekofer AM, Chen C, Ye J, Hameed M, Nafa K, Agaram NP, Cross JR, Khanin R, Mason CE, et al. Induction of sarcomas by mutant IDH2. Genes & Development. 27: 1986-98. PMID 24065766 DOI: 10.1101/Gad.226753.113 |
0.442 |
|
2013 |
Chen C, Liu Y, Lu C, Cross JR, Morris JP, Shroff AS, Ward PS, Bradner JE, Thompson C, Lowe SW. Cancer-associated IDH2 mutants drive an acute myeloid leukemia that is susceptible to Brd4 inhibition. Genes & Development. 27: 1974-85. PMID 24065765 DOI: 10.1101/Gad.226613.113 |
0.455 |
|
2012 |
Chen G, Chen X, King S, Cavassani KA, Cheng J, Zheng X, Cao H, Yu H, Qu J, Fang D, Wu W, Bai X, Liu J, Woodiga SA, Chen C, et al. Erratum: Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction Nature Biotechnology. 30: 193-193. DOI: 10.1038/Nbt0212-193B |
0.408 |
|
2011 |
Zuber J, Rappaport AR, Luo W, Wang E, Chen C, Vaseva AV, Shi J, Weissmueller S, Fellmann C, Fellman C, Taylor MJ, Weissenboeck M, Graeber TG, Kogan SC, Vakoc CR, et al. An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance. Genes & Development. 25: 1628-40. PMID 21828272 DOI: 10.1101/Gad.17269211 |
0.444 |
|
2011 |
Wu Q, Liu Y, Chen C, Ikenoue T, Qiao Y, Li CS, Li W, Guan KL, Liu Y, Zheng P. The tuberous sclerosis complex-mammalian target of rapamycin pathway maintains the quiescence and survival of naive T cells. Journal of Immunology (Baltimore, Md. : 1950). 187: 1106-12. PMID 21709159 DOI: 10.4049/Jimmunol.1003968 |
0.611 |
|
2011 |
Wu Q, Liu Y, Chen C, Ikenoue T, Qiao Y, Li CS, Li W, Guan KL, Liu Y, Zheng P. The tuberous sclerosis complex-mammalian target of rapamycin pathway maintains the quiescence and survival of naive T cells. Journal of Immunology (Baltimore, Md. : 1950). 187: 1106-12. PMID 21709159 DOI: 10.4049/Jimmunol.1003968 |
0.611 |
|
2011 |
Chen GY, Chen X, King S, Cavassani KA, Cheng J, Zheng X, Cao H, Yu H, Qu J, Fang D, Wu W, Bai XF, Liu JQ, Woodiga SA, Chen C, et al. Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction. Nature Biotechnology. 29: 428-35. PMID 21478876 DOI: 10.1038/Nbt.1846 |
0.583 |
|
2011 |
Chen GY, Chen X, King S, Cavassani KA, Cheng J, Zheng X, Cao H, Yu H, Qu J, Fang D, Wu W, Bai XF, Liu JQ, Woodiga SA, Chen C, et al. Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction. Nature Biotechnology. 29: 428-35. PMID 21478876 DOI: 10.1038/Nbt.1846 |
0.583 |
|
2010 |
Li CS, Chen C, Zheng P, Liu Y. Transgenic expression of P1A induced thymic tumor: a role for onco-fetal antigens in tumorigenesis. Plos One. 5: e13439. PMID 20976169 DOI: 10.1371/Journal.Pone.0013439 |
0.607 |
|
2010 |
Li CS, Chen C, Zheng P, Liu Y. Transgenic expression of P1A induced thymic tumor: a role for onco-fetal antigens in tumorigenesis. Plos One. 5: e13439. PMID 20976169 DOI: 10.1371/Journal.Pone.0013439 |
0.607 |
|
2010 |
Chen C, Liu Y, Liu Y, Zheng P. Mammalian target of rapamycin activation underlies HSC defects in autoimmune disease and inflammation in mice. The Journal of Clinical Investigation. 120: 4091-101. PMID 20972332 DOI: 10.1172/JCI43873 |
0.604 |
|
2010 |
Chen C, Liu Y, Liu Y, Zheng P. Mammalian target of rapamycin activation underlies HSC defects in autoimmune disease and inflammation in mice. The Journal of Clinical Investigation. 120: 4091-101. PMID 20972332 DOI: 10.1172/JCI43873 |
0.604 |
|
2009 |
Chen C, Liu Y, Liu Y, Zheng P. mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells. Science Signaling. 2: ra75. PMID 19934433 DOI: 10.1126/scisignal.2000559 |
0.608 |
|
2009 |
Chen C, Liu Y, Liu Y, Zheng P. mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells. Science Signaling. 2: ra75. PMID 19934433 DOI: 10.1126/scisignal.2000559 |
0.608 |
|
2009 |
Wang L, Liu R, Li W, Chen C, Katoh H, Chen GY, McNally B, Lin L, Zhou P, Zuo T, Cooney KA, Liu Y, Zheng P. Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the prostate. Cancer Cell. 16: 336-46. PMID 19800578 DOI: 10.1016/J.Ccr.2009.08.016 |
0.557 |
|
2009 |
Wang L, Liu R, Li W, Chen C, Katoh H, Chen GY, McNally B, Lin L, Zhou P, Zuo T, Cooney KA, Liu Y, Zheng P. Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the prostate. Cancer Cell. 16: 336-46. PMID 19800578 DOI: 10.1016/J.Ccr.2009.08.016 |
0.557 |
|
2009 |
Liu R, Wang L, Chen G, Katoh H, Chen C, Liu Y, Zheng P. FOXP3 up-regulates p21 expression by site-specific inhibition of histone deacetylase 2/histone deacetylase 4 association to the locus. Cancer Research. 69: 2252-9. PMID 19276356 DOI: 10.1158/0008-5472.CAN-08-3717 |
0.584 |
|
2009 |
Liu R, Wang L, Chen G, Katoh H, Chen C, Liu Y, Zheng P. FOXP3 up-regulates p21 expression by site-specific inhibition of histone deacetylase 2/histone deacetylase 4 association to the locus. Cancer Research. 69: 2252-9. PMID 19276356 DOI: 10.1158/0008-5472.CAN-08-3717 |
0.584 |
|
2009 |
Chen C, Liu Y, Liu Y, Zheng P. The axis of mTOR-mitochondria-ROS and stemness of the hematopoietic stem cells. Cell Cycle (Georgetown, Tex.). 8: 1158-60. PMID 19270502 DOI: 10.4161/cc.8.8.8139 |
0.603 |
|
2009 |
Chen C, Liu Y, Liu Y, Zheng P. The axis of mTOR-mitochondria-ROS and stemness of the hematopoietic stem cells. Cell Cycle (Georgetown, Tex.). 8: 1158-60. PMID 19270502 DOI: 10.4161/cc.8.8.8139 |
0.603 |
|
2008 |
Liu R, Wang L, Chen C, Liu Y, Zhou P, Wang Y, Wang X, Turnbull J, Minassian BA, Liu Y, Zheng P. Laforin negatively regulates cell cycle progression through glycogen synthase kinase 3beta-dependent mechanisms. Molecular and Cellular Biology. 28: 7236-44. PMID 18824542 DOI: 10.1128/Mcb.01334-08 |
0.583 |
|
2008 |
Liu R, Wang L, Chen C, Liu Y, Zhou P, Wang Y, Wang X, Turnbull J, Minassian BA, Liu Y, Zheng P. Laforin negatively regulates cell cycle progression through glycogen synthase kinase 3beta-dependent mechanisms. Molecular and Cellular Biology. 28: 7236-44. PMID 18824542 DOI: 10.1128/Mcb.01334-08 |
0.583 |
|
2008 |
Chen C, Liu Y, Liu R, Ikenoue T, Guan KL, Liu Y, Zheng P. TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. The Journal of Experimental Medicine. 205: 2397-408. PMID 18809716 DOI: 10.1084/Jem.20081297 |
0.614 |
|
2008 |
Chen C, Liu Y, Liu R, Ikenoue T, Guan KL, Liu Y, Zheng P. TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. The Journal of Experimental Medicine. 205: 2397-408. PMID 18809716 DOI: 10.1084/Jem.20081297 |
0.614 |
|
2008 |
Chen GY, Chen C, Wang L, Chang X, Zheng P, Liu Y. Cutting edge: Broad expression of the FoxP3 locus in epithelial cells: a caution against early interpretation of fatal inflammatory diseases following in vivo depletion of FoxP3-expressing cells. Journal of Immunology (Baltimore, Md. : 1950). 180: 5163-6. PMID 18390696 DOI: 10.4049/jimmunol.180.8.5163 |
0.629 |
|
2008 |
Chen GY, Chen C, Wang L, Chang X, Zheng P, Liu Y. Cutting edge: Broad expression of the FoxP3 locus in epithelial cells: a caution against early interpretation of fatal inflammatory diseases following in vivo depletion of FoxP3-expressing cells. Journal of Immunology (Baltimore, Md. : 1950). 180: 5163-6. PMID 18390696 DOI: 10.4049/jimmunol.180.8.5163 |
0.629 |
|
2008 |
Chen C, Liu Y, Liu R, Ikenoue T, Guan K, Liu Y, Zheng P. TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species The Journal of Cell Biology. 183: i1-i1. DOI: 10.1083/JCB1831OIA1 |
0.459 |
|
Show low-probability matches. |